Clicky

BiomX Inc.(PHGE)

Description: BiomX Inc., a clinical-stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from dysbiosis of the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases, primary sclerosing cholangitis, and cancer. The company is based in Ness Ziona, Israel.


Keywords: Medicine Cancer Clinical Medicine Disease Autoimmune Disease Chronic Disease Inflammatory Bowel Disease Digestive System Hepatology Bacteriophage Primary Sclerosing Cholangitis

Home Page: www.biomx.com

PHGE Technical Analysis

22 Einstein Street
Ness Ziona, 7414003
Israel
Phone: 972 7 2394 2377


Officers

Name Title
Mr. Jonathan Eitan Solomon MBA CEO & Director
Mr. Assaf Oron Chief Bus. Officer
Dr. Merav Bassan Ph.D. Chief Devel. Officer
Prof. Rotem Sorek Ph.D. Scientific Founder
Dr. Eran Elinav M.D., Ph.D. Scientific Founder
Dr. Timothy K. Lu M.D., Ph.D. Scientific Founder
Ms. Marina Wolfson CPA CFO & Sec.
Ms. Inbal Benjamini-Elran C.H.R.O
Dr. Inbar Gahali-Sass VP of Platform R&D
Dr. Regis A. Vilchez M.D., Ph.D. Sr. VP & Head of Clinical Devel.

Exchange: NYSE MKT

Country: US

Currency: US Dollar ($)

GIC Sector: Health Care
GIC Group: Pharmaceuticals, Biotechnology & Life Sciences
GIC Industry: Biotechnology
GIC Sub-Industry:
Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.1796
Price-to-Sales TTM: 0
IPO Date: 2019-03-13
Fiscal Year End: December
Full Time Employees: 103
Back to stocks